Medtecs International Corporation Limited (TPE:9103)
Taiwan
· Delayed Price · Currency is TWD 5.09
+0.04 (0.79%)
Jun 26, 2025, 1:35 PM CST
TPE:9103 Revenue
In the year 2024, Medtecs International Corporation had annual revenue of $54.42M USD with 3.39% growth. Medtecs International Corporation had revenue of $28.90M in the half year ending December 31, 2024, with 17.28% growth.
Revenue
$54.42M
Revenue Growth
+3.39%
P/S Ratio
0.88
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.56B TWD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 54.42M | 1.78M | 3.39% |
| Dec 31, 2023 | 52.64M | -3.60M | -6.41% |
| Dec 31, 2022 | 56.24M | -87.91M | -60.98% |
| Dec 31, 2021 | 144.16M | -256.17M | -63.99% |
| Dec 31, 2020 | 400.33M | 331.35M | 480.38% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 40.47M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 117.33M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |
| Lumosa Therapeutics | 43.59M |